Generates income from investing in technology-focused portfolio companies and realizing returns via exits, secondary sales, and fair-value revaluations of its holdings. Also earns financial income from cash and money-market fund investments.
Geographic Exposure
IsraelN/A
Revenue Drivers
Life sciences and medical investments
Investments in medical equipment and life sciences portfolio companies
PERIPHERAL0%
Software investments
Investments in software and AI-focused portfolio companies
PERIPHERAL0%
End Markets
Private technology companies seeking growth capital
Strategic acquirers of portfolio companies
Public and private capital markets investors (exit liquidity)
Specializations
IFRS 10 investment entity accountingFair value measurement (FVTPL under IFRS 9)Investment screening criteria and due diligence processMinority-stake investing in private companiesFollow-on investments to prevent dilutionInvestment realization horizon of 5–7 years+2 more
Activities
Deal sourcing and screening
Due diligence and investment evaluation
Making minority equity investments and follow-on anti-dilution investments
Portfolio monitoring and value realization (exits/secondary sales)
